Poor Lung Function, Steroid Use Tied to Risk of Severe COVID-19

Poor Lung Function, Steroid Use Tied to Risk of Severe COVID-19

296727

Poor Lung Function, Steroid Use Tied to Risk of Severe COVID-19

Poor lung function and disease management, along with previous long-term use of corticosteroids, older age, and the presence of cancer are the most significant predictors of severe COVID-19 among people with myasthenia gravis (MG), according to a recent study. The findings also indicated that the odds of death due to COVID-19 were about 35 times higher in MG patients treated with rituximab, an antibody-based therapy used to treat certain autoimmune disease and cancers. Rituximab is…

You must be logged in to read/download the full post.